Pemetrexed versus gefitinib as a second-line treatment in advanced nonsquamous nonsmall-cell lung cancer patients harboring wild-type EGFR (CTONG0806): a multicenter randomized trial

✍ Scribed by Zhou, Q.; Cheng, Y.; Yang, J.- J.; Zhao, M.- F.; Zhang, L.; Zhang, X.- C.; Chen, Z.- H.; Yan, H.- H.; Song, Y.; Chen, J.- H.; Feng, W.- N.; Xu, C.- R.; Wang, Z.; Chen, H.- J.; Zhong, W.- Z.; Liu, Y.- P.; Wu, Y.- L.

• Book ID: 126727427
• Publisher: Oxford University Press
• Year: 2014
• Tongue: English
• Weight: 228 KB
• Volume: 25
• Category: Article
• ISSN: 0923-7534
• DOI: 10.1093/annonc/mdu463